Sherpa funds report 7.2% stake in Alamar Biosciences

Alamar Biosciences disclosure: Sherpa-related entities and manager Daqing Cai reported beneficial ownership of 4,972,134 shares of Common Stock, equal to 7.2% of the class.

Rhea-AI Filing Summary

Alamar Biosciences disclosure: Sherpa-related entities and manager Daqing Cai reported beneficial ownership of 4,972,134 shares of Common Stock, equal to 7.2% of the class. The filing breaks ownership into 3,970,446 shares by Sherpa Healthcare Fund II, L.P. and 1,001,688 shares by Sherpa Healthcare Co-Investment Fund, L.P. The percentage figures use a base of 69,311,186 shares outstanding as of April 30, 2026, per the company Form 10-Q.

Key Figures

Total shares reported for Daqing Cai: 4,972,134 shares Sherpa Healthcare Fund II holdings: 3,970,446 shares Sherpa Co-Investment Fund holdings: 1,001,688 shares +4 more

7 metrics

Total shares reported for Daqing Cai 4,972,134 shares Aggregate beneficial ownership reported on Schedule 13G

Sherpa Healthcare Fund II holdings 3,970,446 shares Sole voting and dispositive power held by Sherpa Healthcare Fund II, L.P.

Sherpa Co-Investment Fund holdings 1,001,688 shares Sole voting and dispositive power held by Sherpa Healthcare Co-Investment Fund, L.P.

Shares outstanding used for percent 69,311,186 shares Shares outstanding as of <date> April 30, 2026 (source: issuer Form 10-Q)

Percent of class (Daqing Cai) 7.2% Calculated based on 69,311,186 shares outstanding as of April 30, 2026

Percent of class (Fund II) 5.7% Sherpa Healthcare Fund II, L.P.'s reported percentage

Percent of class (Co-Investment Fund) 1.4% Sherpa Healthcare Co-Investment Fund, L.P.'s reported percentage

Key Terms

Schedule 13G, Beneficially owned, Sole Voting Power, Shared Dispositive Power, +1 more

5 terms

Schedule 13G regulatory

"represents ... beneficial ownership of common stock (Schedule 13G filing)"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Beneficially owned financial

"Amount beneficially owned: The information required by Item 4(a) is set forth"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power corporate governance

"Sole Voting Power 3,970,446.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Shared Dispositive Power corporate governance

"Shared Dispositive Power 4,972,134.00"

Joint Filing Agreement legal

"Exhibit 99.1 Joint Filing Agreement"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake do Sherpa entities hold in Alamar Biosciences (ALMR)?

Sherpa-related entities beneficially own 4,972,134 shares, reported as 7.2% of Alamar's common stock. This includes 3,970,446 shares by Sherpa Healthcare Fund II, L.P. and 1,001,688 shares by Sherpa Healthcare Co-Investment Fund, L.P.

How was the 7.2% ownership percentage calculated for ALMR?

The filing states the percentage is based on 69,311,186 shares outstanding as of April 30, 2026, as reported in the issuer's Form 10-Q. That base is the denominator used to compute each reporting person’s percent of the class.

Who has voting and dispositive power over the reported ALMR shares?

Sherpa Healthcare Fund II, L.P. holds 3,970,446 shares with sole voting and dispositive power. The general partners (Sherpa Healthcare Fund II GP, Ltd. and Sherpa Healthcare Co-Investment GP Ltd.) and Managing Director Daqing Cai are disclosed as having shared control.

What entities signed the Schedule 13G for ALMR?

The joint filing lists Sherpa Healthcare Fund II, L.P., Sherpa Healthcare Co-Investment Fund, L.P., their GP entities, and Daqing Cai. A Joint Filing Agreement (Exhibit 99.1) is included and signatures are dated 07/02/2026.

Does the filing show any direct purchases or sales of ALMR shares?

No transaction activity is shown; the Schedule 13G reports beneficial ownership positions and voting/dispositive power. The filing lists ownership counts and percentages, but it does not disclose recent buy or sell transactions in this excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 08:46 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Alamar Biosciences, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

010911105

(CUSIP Number)

04/16/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 010911105

1

Names of Reporting Persons

SHERPA HEALTHCARE FUND II, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,970,446.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,970,446.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,970,446.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.7 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: (1) For Rows 5, 7 and 9: represents 3,970,446 shares of common stock held by Sherpa Healthcare Fund II, L.P. The general partner of Sherpa Healthcare Fund II, L.P. is Sherpa Healthcare Fund II GP, Ltd. Daqing Cai is the Managing Director of Sherpa Healthcare Fund II GP, Ltd. and therefore Daqing Cai may be deemed to have shared voting and dispositive control over the shares held by Sherpa Healthcare Fund II, L.P. (2) For Row 11: the percentage of class of securities beneficially owned by each Reporting Person is calculated based on a total of 69,311,186 shares of common stock of the Issuer issued and outstanding as of April 30, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on May 8, 2026.

SCHEDULE 13G

CUSIP Number(s): 010911105

1

Names of Reporting Persons

SHERPA HEALTHCARE CO-INVESTMENT FUND, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,001,688.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,001,688.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,001,688.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.4 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: (1) For Rows 5, 7 and 9: represents 1,001,688 shares of common stock held by Sherpa Healthcare Co-Investment Fund, L.P. The general partner of Sherpa Healthcare Co-Investment Fund, L.P. is Sherpa Healthcare Co-Investment GP Ltd. Daqing Cai is the Managing Director of Sherpa Healthcare Co-Investment GP Ltd. and therefore Daqing Cai may be deemed to have shared voting and dispositive control over the shares held by Sherpa Healthcare Co-Investment Fund, L.P. (2) For Row 11: the percentage of class of securities beneficially owned by each Reporting Person is calculated based on a total of 69,311,186 shares of common stock of the Issuer issued and outstanding as of April 30, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on May 8, 2026.

SCHEDULE 13G

CUSIP Number(s): 010911105

1

Names of Reporting Persons

Sherpa Healthcare Fund II GP, Ltd.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,970,446.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,970,446.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,970,446.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.7 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: (1) For Rows 5, 7 and 9: represents 3,970,446 shares of common stock held by Sherpa Healthcare Fund II, L.P. The general partner of Sherpa Healthcare Fund II, L.P. is Sherpa Healthcare Fund II GP, Ltd. Daqing Cai is the Managing Director of Sherpa Healthcare Fund II GP, Ltd. and therefore Daqing Cai may be deemed to have shared voting and dispositive control over the shares held by Sherpa Healthcare Fund II, L.P. (2) For Row 11: the percentage of class of securities beneficially owned by each Reporting Person is calculated based on a total of 69,311,186 shares of common stock of the Issuer issued and outstanding as of April 30, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on May 8, 2026.

SCHEDULE 13G

CUSIP Number(s): 010911105

1

Names of Reporting Persons

Sherpa Healthcare Co-Investment GP Ltd.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,001,688.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,001,688.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,001,688.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.4 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: (1) For Rows 5, 7 and 9: represents 1,001,688 shares of common stock held by Sherpa Healthcare Co-Investment Fund, L.P. The general partner of Sherpa Healthcare Co-Investment Fund, L.P. is Sherpa Healthcare Co-Investment GP Ltd. Daqing Cai is the Managing Director of Sherpa Healthcare Co-Investment GP Ltd. and therefore Daqing Cai may be deemed to have shared voting and dispositive control over the shares held by Sherpa Healthcare Co-Investment Fund, L.P. (2) For Row 11: the percentage of class of securities beneficially owned by each Reporting Person is calculated based on a total of 69,311,186 shares of common stock of the Issuer issued and outstanding as of April 30, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on May 8, 2026.

SCHEDULE 13G

CUSIP Number(s): 010911105

1

Names of Reporting Persons

Daqing Cai

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,972,134.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,972,134.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,972,134.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.2 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: (1) For Rows 6, 8 and 9: represents (i) 3,970,446 shares of common stock held by Sherpa Healthcare Fund II, L.P., and (ii) 1,001,688 shares of common stock held by Sherpa Healthcare Co-Investment Fund, L.P. The general partner of Sherpa Healthcare Fund II, L.P. is Sherpa Healthcare Fund II GP, Ltd. The general partner of Sherpa Healthcare Co-Investment Fund, L.P. is Sherpa Healthcare Co-Investment GP Ltd. Daqing Cai is the Managing Director of each of Sherpa Healthcare Fund II GP, Ltd. and Sherpa Healthcare Co-Investment GP Ltd., and therefore Daqing Cai may be deemed to have shared voting and dispositive control over the shares held by Sherpa Healthcare Fund II, L.P. and Sherpa Healthcare Co-Investment Fund, L.P. (2) For Row 11: the percentage of class of securities beneficially owned by each Reporting Person is calculated based on a total of 69,311,186 shares of common stock of the Issuer issued and outstanding as of April 30, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on May 8, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Alamar Biosciences, Inc.
(b)	Address of issuer's principal executive offices: 47071 BAYSIDE PARKWAY, FREMONT, CALIFORNIA, 94538.
Item 2.
(a)	Name of person filing: Sherpa Healthcare Fund II, L.P. Sherpa Healthcare Co-Investment Fund, L.P. Sherpa Healthcare Fund II GP, Ltd. Sherpa Healthcare Co-Investment GP Ltd. Daqing Cai
(b)	Address or principal business office or, if none, residence: For each of Sherpa Healthcare Fund II, L.P., Sherpa Healthcare Co-Investment Fund, L.P., Sherpa Healthcare Fund II GP, Ltd. and Sherpa Healthcare Co-Investment GP Ltd.: C/O Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands For Daqing Cai: C/O Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008,Cayman Islands
(c)	Citizenship: For each of Sherpa Healthcare Fund II, L.P., Sherpa Healthcare Co-Investment Fund, L.P., Sherpa Healthcare Fund II GP, Ltd. and Sherpa Healthcare Co-Investment GP Ltd.: Cayman Islands For Daqing Cai: United States
(d)	Title of class of securities: Common Stock, par value $0.0001 per share
(e)	CUSIP Number(s): 010911105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The information required by Item 4(a) is set forth in Rows 5 to 9 of the cover page for each Reporting Person and is incorporated herein by reference.
(b)	Percent of class: The information required by Item 4(b) is set forth in Row 11 of the cover page for each Reporting Person and is incorporated herein by reference.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each Reporting Person and is incorporated herein by reference.
	(ii) Shared power to vote or to direct the vote: The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each Reporting Person and is incorporated herein by reference.
	(iii) Sole power to dispose or to direct the disposition of: The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each Reporting Person and is incorporated herein by reference.
	(iv) Shared power to dispose or to direct the disposition of: The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each Reporting Person and is incorporated herein by reference.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

SHERPA HEALTHCARE FUND II, L.P.

Signature:	Daqing Cai
Name/Title:	Daqing Cai, Director of Sherpa Healthcare Fund II GP, Ltd., the general partner of Sherpa Healthcare Fund II, L.P.
Date:	07/02/2026

SHERPA HEALTHCARE CO-INVESTMENT FUND, L.P.

Signature:	Daqing Cai
Name/Title:	Daqing Cai, Director of Sherpa Healthcare Co-Investment GP Ltd., the general partner of Sherpa Healthcare Co-Investment Fund, L.P.
Date:	07/02/2026

Sherpa Healthcare Fund II GP, Ltd.

Signature:	Daqing Cai
Name/Title:	Daqing Cai, Director
Date:	07/02/2026

Sherpa Healthcare Co-Investment GP Ltd.

Signature:	Daqing Cai
Name/Title:	Daqing Cai, Director
Date:	07/02/2026

Daqing Cai

Signature:	Daqing Cai
Name/Title:	Daqing Cai
Date:	07/02/2026

Exhibit Information

Exhibit 99.1 Joint Filing Agreement